Month: August 2025
NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Xcel Brands (NASDAQ: XELB), a leading media and consumer products company known for building socially driven, live-commerce-focused brands, today announced the pricing of its public offering of 2,181,818 shares of common stock at a public offering price of $1.10 per share. In a concurrent private placement, the Company also agreed to issue and sell an aggregate of 145,147 unregistered shares to certain insiders of the Company including the Company’s Chief Executive Officer, Robert D’Loren, at a purchase price of $1.36, which is equal to the closing price of the Company’s common stock on July 31, 2025. The closing of the offering is expected to occur on or about August 4, 2025, subject to the satisfaction of customary closing conditions.
Maxim Group LLC is acting as the sole placement...
Form 8.3 – [Alpha Group International]
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION(a) Full name of discloser:
Danske Bank A/S(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree
Alpha Group International PLC (GB)(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: For...
Nightfood Holdings Advances $80 Million in Strategic Hotel Acquisitions to Anchor AI-Powered Hospitality Platform
Written by Customer Service on . Posted in Public Companies.
Landmark closings expected this quarter position company for leadership in $170 billion service robotics market
TARRYTOWN, N.Y., Aug. 01, 2025 (GLOBE NEWSWIRE) — via IBN – Nightfood Holdings, Inc. (OTCQB: NGTF), a company redefining the future of hospitality through AI-powered automation and strategic hotel asset ownership, today announces it is on track to finalize due diligence and enter definitive agreements for the acquisition of two flagship hotel properties in Victorville and Rancho Mirage, California. Combined, these transactions represent approximately $80 million in institutional-grade real estate assets and serve as a cornerstone of the company’s vertically integrated hospitality and automation strategy.
Following its recent acquisitions of Skytech Automated Solutions, Future Hospitality Ventures and Carryout Supplies,...
Nexalin Technology Appoints Highly Experienced Financial Leader Justin Van Fleet as CFO to Support Nexalin’s Next Phase of Growth and Strategic Initiatives
Written by Customer Service on . Posted in Public Companies.
HOUSTON, TX, Aug. 01, 2025 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced the appointment of Justin Van Fleet, CPA, as Chief Financial Officer, effective August 1, 2025.
Mr. Van Fleet brings more than 20 years of experience in public accounting and assurance services, most recently serving as Partner at Marcum LLP (formerly Friedman LLP). In this role, he led the firm’s assurance practice and advised both publicly traded and privately held clients across a wide range of sectors including technology, life sciences, manufacturing, and distribution. He is widely recognized for his integrity, technical expertise, and strategic leadership, particularly in guiding companies through complex...
Empro Group Inc. Announces Closing of Remaining Portion of the Underwriter’s Over-Allotment Option in Connection with its Upsized Initial Public Offering
Written by Customer Service on . Posted in Public Companies.
Selangor, Malaysia, Aug. 01, 2025 (GLOBE NEWSWIRE) — Empro Group Inc. (the “Company” or “EMPG”), a rising beauty and personal care brand headquartered in Malaysia, today announced that it closed the sales of an additional 91,250 ordinary shares of the Company, representing the exercise of the remaining portion of the underwriter’s over-allotment option granted in connection with the Company’s initial public offering (the “IPO”, and together with such over-allotment closing, the “Offering”), at the IPO price of $4.00 per share, less underwriting discounts. As a result, the Company has raised gross proceeds of $365,000 in addition to the previously announced IPO gross proceeds of approximately $5,500,000 and the previously announced gross proceeds of $460,000 arising from the partial exercise by the underwriter of its over-allotment...
The North West Company Inc. Announces Appointment of Gregg Saretsky as a Director
Written by Customer Service on . Posted in Public Companies.
WINNIPEG, Manitoba, Aug. 01, 2025 (GLOBE NEWSWIRE) — The North West Company Inc. (“North West”) is pleased to announce the appointment of Gregg Saretsky as a director of North West, effective today.
Gregg Saretsky is a seasoned corporate director with deep experience in the global aviation industry. He currently serves on the board of directors of InterGlobe Aviation Limited, India’s largest airline, and on the board of directors of Southwest Airlines. From 2010 to 2018, Mr. Saretsky served as President and Chief Executive Officer of WestJet Airlines Ltd., and he previously held senior-level commercial and operational roles at Alaska Air Group, Inc. and, prior to its acquisition by Air Canada, Canadian Airlines International Ltd. Mr. Saretsky earned a B.Sc. and an M.B.A. from the University of British Columbia.
“We are very pleased...
SecureTech Announces Uplisting to OTCQB Venture Market
Written by Customer Service on . Posted in Public Companies.
Roseville, Minnesota, Aug. 01, 2025 (GLOBE NEWSWIRE) — SecureTech Innovations, Inc. (OTCQB: SCTH), a pioneering technology company advancing artificial intelligence, industrial 3D printing and manufacturing technologies, cybersecurity, and digital infrastructure solutions, is pleased to announce that its common stock has been approved for trading on the OTCQB® Venture Market, effective immediately.
The OTCQB Venture Market, operated by OTC Markets Group Inc., is recognized by the U.S. Securities and Exchange Commission (SEC) as an established public market, the first tier within the OTC framework to receive such recognition. It serves early-stage and developing U.S. and international companies that meet strict financial standards, maintain current reporting with the SEC or a U.S. banking regulator, and complete annual verification...
Allogene Therapeutics Moves Forward with Standard Fludarabine and Cyclophosphamide (FC) Lymphodepletion Regimen in the ALPHA3 Trial for Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation for Large B-Cell Lymphoma
Written by Customer Service on . Posted in Public Companies.
Lymphodepletion Regimen Selection Made in Conjunction with the ALPHA3 Data and Safety Monitoring Board (DSMB) and Steering Committee, and in Consultation with the FDA Following an ALLO-647-Related Death in the FCA (FC plus ALLO-647) Lymphodepletion Arm
Unplanned Review of Safety and Biomarker Data with Standard FC and Cema-cel Indicates Encouraging MRD Conversion Rate and Safety Profile
ALPHA3 Study Now Proceeds as a Two-Arm Randomized Study Comparing Cema-cel After Standard FC Lymphodepletion to Observation; Scheduled Futility Analysis Remains 1H 2026, as Planned
Conference Call and Webcast Scheduled for Today at 8:00 AM PT/11:00 AM ETSOUTH SAN FRANCISCO, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T...
IRADIMED CORPORATION Reports Record Second Quarter 2025 Financial Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Announces Regular Quarterly Cash Dividend of $0.17 Per Share
Raises Full Year 2025 Revenue and Earnings GuidanceReports record revenue of $20.4 million for the second quarter of 2025, an increase of $2.5 million, or 14%, compared to the same period in 2024.
Reports record GAAP diluted EPS of $0.45 and non-GAAP diluted EPS of $0.49 for the second quarter of 2025, which are increases of 18% and 17%, respectively, compared to the same period in 2024.
Declares a regular quarterly cash dividend of $0.17 per share of common stock for the third quarter of 2025, payable on August 28, 2025.ORLANDO, Fla., Aug. 01, 2025 (GLOBE NEWSWIRE) — IRADIMED CORPORATION (the “Company” or “Iradimed”) (NASDAQ: IRMD) announced today its financial results for the three and six months ended June 30, 2025. The Company is a leader in developing innovative...
Ocugen Provides Business Update with Second Quarter 2025 Financial Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Conference Call and Webcast Today at 8:30 a.m. ETInitiated dosing in OCU410ST Phase 2/3 GARDian3 pivotal confirmatory clinical trial
Actively dosing patients in OCU400 Phase 3 liMeliGhT clinical trial and on track for 2026 BLA filing
OrthoCellix reverse merger intended to unlock the value of NeoCart/regenerative cell therapies and enable the Company to focus capital on modifier gene therapy platform
Signed binding term sheet for exclusive Korean rights to OCU400 with upfront fees and near-term development milestone payments totaling up to $11 millionMALVERN, Pa., Aug. 01, 2025 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today reported second quarter 2025 financial results along with a business update.
“While our modifier...